Chill Brands Group PLC CHLL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 2.50
- Day Range
- GBX 2.30–2.70
- 52-Week Range
- GBX 1.70–14.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 1.16 Bil
- Volume/Avg
- 150,828 / 2.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 44.56
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chill Brands Group PLC is engaged in the development, production, and distribution of CBD and lifestyle products. The CBD business sells wellness products in the United States and the United Kingdom under two brands Zoetic and Chill ranges. The chill brand is a tobacco alternative selling smokables and chew pouches. It generates revenue from the sale of CBD products. Geographically, group’s revenue is generated in the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 5
- Website
- https://www.chillbrandsgroup.com
Valuation
|
Metric
|
CHLL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 44.56 |
Price/Cash Flow | — |
Price/Earnings
CHLL
Financial Strength
|
Metric
|
CHLL
|
|---|---|
Quick Ratio | 0.65 |
Current Ratio | 0.82 |
Interest Coverage | −7.56 |
Quick Ratio
CHLL
Profitability
|
Metric
|
CHLL
|
|---|---|
Return on Assets (Normalized) | −63.03% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −60.73% |
Return on Assets
CHLL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Chwmqfdcq | Fxnz | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Kykkvkflx | Xqctry | $72.0 Bil | |
HLN
| Haleon PLC ADR | Vnlycnbj | Wrd | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nhqndydxl | Rvv | $17.8 Bil | |
VTRS
| Viatris Inc | Hvscpsq | Sjtkx | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qttpjxl | Xpmxb | $12.5 Bil | |
CTLT
| Catalent Inc | Mnhjtpdby | Glnvjrb | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Ydxxdgcj | Dmjl | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Lnnfzfpr | Dyhy | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Chhflbjd | Dtktkyj | $3.5 Bil |